Head-to-head · WeighScore
LIV by WellNow vs TeleClinic
The verdict
LIV by WellNow takes it — 62.9/100 to 60.8/100.
LIV by WellNow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LIV by WellNow is the telehealth weight-management arm of WellNow Urgent Care, offering compounded semaglutide for weight loss.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | LIV by WellNow | TeleClinic |
|---|---|---|
| WeighScore | 62.9/100 | 60.8/100 |
| Grade | C | C |
| Scorecard rank | #262 | #313 |
| Semaglutide | $279/mo | $199/mo (compounded) |
| Tirzepatide | Not disclosed | $299/mo (compounded) |
| Coverage | 5 states | 47 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #262 · C
Strengths
- Flat $279/month covers medication, supplies, and unlimited virtual visits
- Backed by established WellNow Urgent Care brand
- Board-certified online medical providers
- Same-day approval and monthly home delivery
- Transparent all-inclusive pricing with no hidden fees
Where it loses points
- Compounded semaglutide is not FDA-approved or evaluated
- Only available in five states (IL, IN, MI, NY, PA)
- No tirzepatide option offered
- Insurance not accepted for compounded semaglutide
Graded #313 · C
Strengths
- Names its pharmacy partner — Rush Pharmacy, a licensed 503A compounder — which many compounded-GLP-1 telehealths won't disclose
- LegitScript certified with flat, published monthly pricing, free shipping, and no insurance required
- Broad access: 47 states with US-licensed physicians and transparent cash-pay pricing
Where it loses points
- Compounded semaglutide and tirzepatide only — no brand-name GLP-1 (Wegovy or Zepbound) option
- Headline $139/$219 rates are first-quarter intro prices billed quarterly; ongoing month-to-month is $199/$299
- Not available in California, South Carolina, or New Jersey
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.